Boundless Bio Inc (BOLD)

Currency in USD
1.19
+0.04(+3.48%)
Closed·
After Hours
1.20+0.01(+0.84%)
·
BOLD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BOLD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.151.22
52 wk Range
1.004.72
Key Statistics
Prev. Close
1.19
Open
1.15
Day's Range
1.15-1.22
52 wk Range
1-4.72
Volume
84.53K
Average Volume (3m)
171.88K
1-Year Change
-66.67%
Book Value / Share
6.13
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BOLD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.00
Upside
+236.13%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

Boundless Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Boundless Bio Inc Company Profile

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company’s lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Compare BOLD to Peers and Sector

Metrics to compare
BOLD
Peers
Sector
Relationship
P/E Ratio
−0.4x−4.4x−0.5x
PEG Ratio
0.000.020.00
Price/Book
0.2x3.0x2.6x
Price / LTM Sales
-8.6x3.2x
Upside (Analyst Target)
247.8%172.6%42.7%
Fair Value Upside
Unlock16.3%5.8%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4.00
(+236.13% Upside)

Earnings

Latest Release
May 09, 2025
EPS / Forecast
0.71 / -1.02
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BOLD Income Statement

People Also Watch

7.790
GVH
+8.80%
2.20
BMGL
-5.98%
44.440
SMR
-2.20%
4.270
GBIO
+1.43%
57.61
ETOR
+2.55%

FAQ

What Stock Exchange Does Boundless Bio Trade On?

Boundless Bio is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Boundless Bio?

The stock symbol for Boundless Bio is "BOLD."

What Is the Boundless Bio Market Cap?

As of today, Boundless Bio market cap is 26.64M.

What Is Boundless Bio's Earnings Per Share (TTM)?

The Boundless Bio EPS (TTM) is -2.95.

When Is the Next Boundless Bio Earnings Date?

Boundless Bio will release its next earnings report on 17 Aug 2025.

From a Technical Analysis Perspective, Is BOLD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Boundless Bio Stock Split?

Boundless Bio has split 0 times.

How Many Employees Does Boundless Bio Have?

Boundless Bio has 64 employees.

What is the current trading status of Boundless Bio (BOLD)?

As of 23 Jul 2025, Boundless Bio (BOLD) is trading at a price of 1.19, with a previous close of 1.19. The stock has fluctuated within a day range of 1.15 to 1.22, while its 52-week range spans from 1.00 to 4.72.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.